Accord Eye Study - Two Treatments may Help Diabetics Slow Progression of Eye Diseases
Type 2 Diabetes & Diabetic Retinopathy
One of the risk factors for people with type 2 diabetes is diabetic retinopathy which can lead to blindness. Diabetic retinopathy is an eye disease where the blood vessels in the light sensitive retina tissue become damage by the diabetes. The damage blood vessels can start to leak, causing swelling in the retina. This cause new abnormal blood vessels to develop both of which can cause a severe loss of sight and even blindness.
The Clinical Study
The clinical study involved 2,856 diabetics. The study lasted for a period of four years. The diabetics who were able to manage their diabetes and keep their glucose levels stable showed a decrease in the progression of diabetic retinopathy. The diabetics in the study who had unstable/unmanaged diabetes showed an increase in diabetic retinopathy.
With simvastatin treatment combined with lipid therapy with fenofibrate reduced the progression by one-third. These three treatments working together showed an impressive decrease in diabetic retinopathy.